Skip to main content

Abstract

The discovery that human brain contains peptides with opioid activity has created a worldwide research effort. Since opiate alkaloids have a profound influence on pain, mood, and behavior in man, the hypothesis has arisen that certain mental disorders could be connected with a dysfunction of the endorphin systems. The first direct evidence for this hypothesis was obtained from a small group of schizophrenic patients, who were found to have increased concentrations of two endorphin fractions in the cerebrospinal fluid (CSF) in a drug-free state (Terenius et al., 1976). This finding was supported by later studies (Lindström et al., 1978; Rimon et al., 1980); furthermore, patients with manic-depressive disorders and puerperal psychosis have been found to have increased levels of endorphins in CSF (Terenius et al., 1977; Lindström et al., 1978) and plasma (Pickar et al., 1980). Indirect support for the hypothesis comes from studies with the opiate antagonist naloxone. A decrement especially of auditory hallucinations has been reported in selected patients (Gunne et al., 1977; Emrich et al., 1977; Watson et al., 1978), but others have failed to replicate these results (Table 1). A relationship between endorphins and mental disturbances has also been suggested by several investigators (Bloom et al., 1976; Jacquet and Marks, 1976; Herz, 1976; Byck, 1976; for a review see Verebey et al., 1978; Watson et al., 1979; Davis et al., 1979).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akil, H., Watson, S.J., Sullivan, S., and Barchas, J.D., 1978, Enkephalin-like material in normal human CSF: Measurement and levels, Life Sci. 23: 121.

    Article  Google Scholar 

  • Asberg, M., Montgomery, S.A., Perris, C., Schalling, D., and Sedvall, G., 1978, A com- prehensive psychopathological rating scale, Acta Psychiatr. Scand. Suppl. 271: 5.

    Article  Google Scholar 

  • Bloom, F., Segal, D., Ling, N., and Guillemin, R., 1976, Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness, Science 194: 630.

    Article  Google Scholar 

  • Burbach, J.P.H., Loeber, J.G., Verhoef, J., de Kloet, E.R., van Ree, J.M., and de Wied, D., 1979, Schizophrenia and degradation of endorphins in cerebrospinal fluid, Lancet 2: 480.

    Google Scholar 

  • Byck, R., 1976, Peptide transmitters: A unifying hypothesis for euphoria, respiration, sleep and the action of lithium, Lancet 2: 72.

    Article  Google Scholar 

  • Davis, G.C., Bunney, W.E., Jr., DeFraites, E.G., Kleinman, J.E., van Kammen, D.P., Post, R.M., and Wyatt, R.J., 1977, Intravenous naloxone administration in schizophrenia and affective illness, Science 197: 74.

    Article  Google Scholar 

  • Davis, G.C., Buchsbaum, M.S., and Bunney, W.E., Jr., 1979, Research in endorphins and schizophrenia, Schizophrenia Bull. 5: 244.

    Google Scholar 

  • Domschke, W., Dickschas, A., and Mitznegg, P., 1979, CSF 13-endorphin in schizophrenia, Lancet 1: 1024.

    Google Scholar 

  • Dupont, A., Villeneuve, A., Bouchard, J.P., Bouchard, R., Mérand, Y., Rouleau, D., and Labrie, F., 1978, Rapid inactivation of enkephalin-like material by CSF in chronic schizophrenia, Lancet 2: 1107.

    Article  Google Scholar 

  • Emrich, H.M., Cording, C., Pirée, S., Kölling, A., von Zerssen, D., and Herz, A., 1977, Indication of an antipsychotic action of the opiate antagonist naloxone, Pharmakopsychiatr. Neuro-Psychopharmakol. 10: 265.

    Google Scholar 

  • Emrich, H.M., Cording, C., Pirée, S., Kölling, A., Möller, H.J., von Zerssen, D., and Herz, A., 1979, Actions of naloxone in different types of psychoses, in: Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 452–460, Oxford University Press, London.

    Google Scholar 

  • Gunne, L.-M., Lindström, L., and Terenius, L., 1977, Naloxone-induced reversal of schizophrenic hallucinations, J. Neural Transm. 40: 13.

    Article  Google Scholar 

  • Gunne, L.-M., Lindström, L.H., and Widerlöv, E., 1979, Possible role of endorphins in schizophrenia and other psychiatric disorders, in: Endorphins in Mental Health Research ( E. Usdin, W.E. Bunney, Jr., and N. S. Kline, eds.), pp. 547–552, Oxford University Press, London.

    Google Scholar 

  • Herz, A., 1976, Recent developments in opiate research and their implications for psychiatry, Arch. Psychiatr. Nervenkr. 221 (3): 183.

    Article  Google Scholar 

  • Jacquet, Y.F., and Marks, N., 1976, The C-fragment of 3-lipotropin: An endogenous neuroleptic or antipsychotogen?, Science 194: 632.

    Article  Google Scholar 

  • Janowsky, D.S., Segal, D.S., Bloom, F., Abrams, A., and Guillemin, R., 1977, Lack of effect of naloxone on schizophrenic symptoms, Am. J. Psychiatry 134: 926.

    Google Scholar 

  • Jeffcoate, W.J., Rees, L.H., McLoughlin, L., Ratter, S.J., Hope, J., Lowry, P.J., and Besser, G.M., 1978, I3-Endorphins in human cerebrospinal fluid, Lancet 2: 119.

    Article  Google Scholar 

  • Kurland, A.A., McCabe, O. L., Hanlon, T. E., and Sullivan, D., 1977, The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride, Am. J. Psychiatry 134: 1408.

    Google Scholar 

  • Lindström, L.H., Widerlöv, E., Gunne, L.-M., Wahlström, A., and Terenius, L., 1978, Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states, Acta Psychiatr. Scand. 57: 153.

    Article  Google Scholar 

  • Orr, M., and Oppenheimer, C., 1978, Effects of naloxone on auditory hallucinations, Br. Med. J. 1: 481.

    Article  Google Scholar 

  • Pickar, D., Cutler, N.R., Naber, D., Post, R.M., Pert, C.B., and Bunney, W.E., Jr., 1980, Plasma opioid activity in manic-depressive illness, Lancet 1: 937.

    Article  Google Scholar 

  • Rimon, R., Terenius, L., and Kampman, R., 1980, Cerebrospinal fluid endorphins in schizophrenia, Acta Psychiatr. Scand. 61: 395.

    Article  Google Scholar 

  • Terenius, L., 1974, A rapid assay of affinity for the narcotic receptor in rat brain: Application to methadone analogues, Acta Pharmacol. Toxicol. 34: 88.

    Article  Google Scholar 

  • Terenius, L., and Wahlström, A., 1975, Morphine-like ligand for opiate receptors in human CSF, Life Sci. 16: 1759.

    Article  Google Scholar 

  • Terenius, L., Wahlström, A., Lindström, L. H., and Widerlöv, E., 1976, Increased CSF levels of endorphins in chronic psychosis, Neurosci. Lett. 3: 157.

    Article  Google Scholar 

  • Terenius, L., Wahlström, A., and Agren, H., 1977, Naloxone (Narcan) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites, Psychopharmacologia 54: 31.

    Article  Google Scholar 

  • Verebey, K., Volavka, J., and Clouet, D., 1978, Endorphins in psychiatry: An overview and a hypothesis, Arch. Gen. Psychiatry 35: 877.

    Article  Google Scholar 

  • Volavka, J., Mallya, A., Baig, S., and Perez-Cruet, J., 1977, Naloxone in chronic schizophrenia, Science 196: 1227.

    Article  Google Scholar 

  • Watson, S.J., Berger, P.A., Akil, H., Mills, M.J., and Barchas, J.D., 1978, Effects of naloxone on schizophrenia: Reduction in hallucinations in a subpopulation of subjects, Science 201: 73.

    Article  Google Scholar 

  • Watson, S.J., Akil, H., Berger, P.A., and Barchas, J.D., 1979, Some observations on the opiate peptides and schizophrenia, Arch. Gen. Psychiatry 36: 35.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Plenum Publishing Corporation

About this chapter

Cite this chapter

Lindström, L.H. et al. (1982). Cerebrospinal Fluid Content of Endorphins in Schizophrenia. In: Shah, N.S., Donald, A.G. (eds) Endorphins and Opiate Antagonists in Psychiatric Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1119-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1119-5_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1121-8

  • Online ISBN: 978-1-4684-1119-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics